Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge

• Hoofdauteurs: Shuren Zhang (Auteur), Gan Zhao (Auteur), Caixia Su (Auteur), Chaofan Li (Auteur), Xian Zhou (Auteur), Weidong Zhao (Auteur), Yiwei Zhong (Auteur), Zhonghuai He (Auteur), Haichang Peng (Auteur), Aihua Dong (Auteur), Bin Wang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2020-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Although respiratory syncytial virus (RSV) infection in infants and young children is a global public health issue, development of a safe RSV vaccine has been impeded by formalin-inactivated RSV-enhanced respiratory disease (ERD). In developing a safer yet effective RSV vaccine for children, a strat...